Best Oligonucleotide / ASO CDMOs in Germany
· updated as new inspection, certificate, and trial data enters the platform
7
CDMOs tracked
2
Fully scored
2
With FDA records
5
FDA inspections
10
EMA/MHRA GMP certs
Oligonucleotide CDMOs make antisense oligonucleotides (ASOs), siRNAs, and related nucleic-acid drugs by solid-phase synthesis, with downstream purification and conjugation (e.g. GalNAc). The segment has grown sharply alongside approved ASO and siRNA therapeutics.
Choosing an oligonucleotide CDMO turns on synthesis scale, chemistry breadth (phosphorothioate backbones, 2'-modifications, conjugation), purity, and a clean regulatory record. The rankings below score each CDMO on FDA inspections, GMP certification, clinical activity, and capacity.
FDA inspection outcomes across these CDMOs: 1 NAI (no action), 4 VAI (voluntary action), 0 OAI (official action). Leading inspection & GMP sites: Germany (4), Italy (4), Portugal (4), United States (2), France (1).
Last updated 2026-08-27. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
| # | CDMO | Signal Score | Quality | FDA · GMP | Capacity | Programs |
|---|---|---|---|---|---|---|
| 1 |
AX
Axolabs (Nuvisan)
Kulmbach, Germany
|
72.5 | 98.8 | 1 insp · 0 GMP | — | 3 programs |
| 2 |
CD
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
|
82.5 | 99.7 | 4 insp · 10 GMP | — | 0 programs |
| — |
Coriolis Pharma
Martinsried (Munich), Germany
|
Profiled | — | — | — | 0 programs |
| — |
Vetter Pharma International GmbH
Ravensburg, Germany
|
Profiled | — | — | — | 0 programs |
| — |
BioSpring GmbH
Frankfurt, Germany
|
Profiled | — | — | — | 0 programs |
| — |
Axplora
Raubling, Germany
|
Profiled | — | — | — | 0 programs |
| — |
medac GmbH (medac CDMO)
Wedel, Germany
|
Profiled | — | — | — | 0 programs |
What to evaluate in a Oligonucleotide / ASO CDMO
Synthesis scale
Match synthesizer scale (mmol to mol) to your clinical and commercial demand, and confirm the CDMO can scale without shifting the impurity profile.
Chemistry & conjugation
Confirm experience with your backbone and modifications (phosphorothioate, 2'-MOE/F) and any conjugation (GalNAc, lipid) your molecule requires.
Purity & analytics
Full-length product, deletion/addition impurities, and residual metals drive release. Look for established orthogonal analytics.
Regulatory track record
Cross-check FDA 483 history and EMA/MHRA GMP coverage — both shown above and on each profile.
What makes the German CDMO cluster distinctive within Europe?
Germany's CDMO base combines three attributes that shape sponsor decisions: (1) strong biologics + advanced-therapy depth — BioNTech's Marburg site is one of the largest single-facility mRNA operations globally, Boehringer Ingelheim BioXcellence operates commercial-scale biologics at Biberach, and Rentschler carries deep mAb + biosimilar experience; (2) engineering discipline — German pharmaceutical manufacturing has a reputation for process rigor that translates into strong FDA and EMA inspection outcomes; (3) proximity to European pharmaceutical R&D centers, which reduces tech-transfer coordination cost. German CDMOs generally hold BfArM + EMA + MHRA + FDA certifications concurrently for global-market-supplying facilities.
Which German CDMOs specialize in advanced-therapy modalities (viral vector, cell therapy, mRNA)?
Germany hosts substantial advanced-therapy CDMO capacity. Cross-reference with modality pages to filter: mRNA CDMOs (BioNTech Manufacturing Services is Germany's largest), AAV CDMOs, lentiviral CDMOs, cell therapy CDMOs, or the viral vector umbrella. The individual CDMO profile pages surface facility-level modality coverage — critical for advanced-therapy programs where the specific German site's containment class and analytics platform matter more than country-level aggregates.
German CDMOs supplying US and Asian markets
German CDMOs with FDA and Asian regulator inspection history qualify to supply global markets; those without cross-jurisdictional inspection posture are typically limited to EU and MHRA scope. Cross-check with the US region ranking and Asia region ranking to identify German-headquartered CDMOs with global footprint. The Signal Score's Quality Compliance pillar captures FDA + EMA + MHRA data directly, so cross-jurisdictional German CDMOs typically rank higher on this pillar than EU-only competitors.
Oligonucleotide / ASO CDMOs — Frequently Asked Questions
Who are the top Oligonucleotide / ASO CDMOs?
By CDMO Signal's independent Signal Score, the top-ranked Oligonucleotide / ASO CDMOs include Axolabs (Nuvisan), Corden Pharma. See the full ranked table above — scored on FDA, clinical, financial, and capacity data.
How many Oligonucleotide / ASO CDMOs have FDA inspection records?
CDMO Signal tracks 2 Oligonucleotide / ASO CDMOs with FDA inspection records and 10 EMA/MHRA GMP certificates across the group.
What should I look for in an oligonucleotide CDMO?
Match synthesis scale to your demand, confirm experience with your backbone chemistry and any conjugation (e.g. GalNAc), prioritize strong purity analytics, and a clean FDA and EMA/MHRA record.
What therapeutics do oligonucleotide CDMOs make?
Antisense oligonucleotides (ASOs), siRNAs, aptamers, and related nucleic-acid drugs — increasingly with conjugation chemistries like GalNAc for targeted delivery.
Related modalities